Ovarian and Prostate Cancer: Promising New Drug

Studies are ongoing for the evaluation of P.O. and I.V. phenoxodial in resistant prostate and ovarian cancers. To date the results are encouraging with responses noted in patients with advanced disease.

Reference: AACR 95th Annual meeting March 27-31 2004, Orlando Fl.

Webmaster

August 03, 2004